GFPT1 Antibody

Code CSB-PA009377GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
GFPT1
Alternative Names
CMS12 antibody; CMSTA1 antibody; D-fructose-6-phosphate amidotransferase 1 antibody; GFA antibody; GFAT 1 antibody; GFAT antibody; GFAT1 antibody; GFAT1m antibody; GFPT antibody; Gfpt1 antibody; GFPT1_HUMAN antibody; GFPT1L antibody; Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 antibody; Glutamine--fructose-6-phosphate transaminase 1 antibody; Glutamine:fructose 6 phosphate amidotransferase 1 antibody; Hexosephosphate aminotransferase 1 antibody; MSLG antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human GFPT1
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB,IHC,IF
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Regulates the circadian expression of clock genes ARNTL/BMAL1 and CRY1.
Gene References into Functions
  1. high GFAT1 expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic cancer patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies. PMID: 27996048
  2. study reports nine new mutations of GFPT1 in limb-girdle congenital myasthenic syndrome (LG-CMS) PMID: 28712002
  3. Findings indicate that GFAT1 functions as a novel suppressor of EMT and tumor metastasis in gastric cancer. PMID: 27509259
  4. GNPDA1 siRNA induced GFAT2 which was hardly measurable in these cells under standard culture conditions, GNPDA2 siRNA increased GFAT1, and GFAT1 siRNA increased the expression of hyaluronan synthase 2 (HAS2). Silencing of GFAT1 stimulated GNPDA1 and GDPDA2, and inhibited cell migration. PMID: 26887390
  5. High GFAT1 expression is associated with hepatocellular carcinoma. PMID: 28186970
  6. mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1, and is essential for proper expression and nuclear accumulation of the GFAT1 transcriptional regulator, Xbp1s. PMID: 27570073
  7. GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis. PMID: 28008135
  8. The AMPK-GFAT1 signaling axis serves as an important communication point between two nutrient-sensitive signaling pathways and is likely to play a significant role in controlling physiological processes in many other tissues. PMID: 28336748
  9. Increased GFPT1 expression is associated with triple-negative breast cancer. PMID: 26715276
  10. This study demonstrated that Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. PMID: 21975507
  11. 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome PMID: 25765662
  12. Two GFPT1 untranslated mutations may cause limb-girdle myasthenia by reducing GFPT1 expression and ultimately impairing protein glycosylation. PMID: 23488891
  13. Mapping of the regulatory site of glucosamine-6P synthase identified critical residues necessary for catalysis. PMID: 24075873
  14. Inhibition of GFPT1 enzymatic activity or siRNA silencing of GFPT1 expression resulted in reduced AChR expression. PMID: 23569079
  15. The results found no correlation between end plate morphology and physiology or between genotype and phenotype in GFPT1-myasthenia. PMID: 23794683
  16. GFPT1 is the key enzyme in the hexosamine biosynthesis pathway. Mutations in GFPT1 cause defective glycosylation in the proteins of the neuromuscular junction. PMID: 22987706
  17. Downregulation of the GFPT1 is associated with neuromuscular transmission defect. PMID: 21310273
  18. An increased concentration of wild-type GFAT in mesangial cells is enhanced both TGF-beta1 and fibronectin PMID: 12802498
  19. Genetic variation in GFPT1 is unlikely to have a major impact on susceptibility to diabetic nephropathy. PMID: 14988277
  20. Variants in the GFPT1 gene show suggestive evidence of an association with diabetic nephropathy among African-American individuals, and increased GFPT1 gene expression may characterize Caucasian subjects with diabetic nephropathy. PMID: 15308130
  21. On the basis of the docking results, a binding pocket of human GFAT1 dimer for UDP-GlcNAc is defined. PMID: 15595739
  22. two polymorphisms in the 5'-flanking region of GFAT, of which the -913 polymorphism seems to alter the risk for obesity and intramyocellular lipid accumulation in male subjects. PMID: 15613432
  23. A novel single nucleotide polymorphism identified at position -1412 (G to C) had a functional effect on promoter activity and EMSA revealed specific binding of nuclear proteins to this region. PMID: 15878746
  24. Testing for association of an +36T>C polymorphism in the glutamine: fructose-6-phosphate amidotransferase 1 gene and type 2 diabetes in Japanese and Caucasians. PMID: 17024311
  25. These findings suggest for the first time that hGfat1 may be regulated by kinases other than PKA. PMID: 17941647
  26. The first structures of the isomerase domain of the human GFAT in the presence of cyclic glucose-6-phosphate and linear glucosamine-6-phosphate was reported. PMID: 19059404
  27. The phosphorylation of GFAT1 at Ser243 by AMPK has an important role in the regulation of the GFAT1 enzymatic activity. PMID: 19170765
  28. A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle. PMID: 11679416
  29. expression profiles of GFAT1 mRNA in various human tissues using reverse transcriptase-polymerase chain reaction. The identification and cDNA cloning of a novel GFAT1 splice variant expressed abundantly in skeletal muscle and heart is reported. PMID: 11587069

Show More

Hide All

Involvement in disease
Myasthenic syndrome, congenital, 12 (CMS12)
Tissue Specificity
Isoform 1 is predominantly expressed in skeletal muscle. Not expressed in brain. Seems to be selectively expressed in striated muscle.
Database Links

HGNC: 4241

OMIM: 138292

KEGG: hsa:2673

STRING: 9606.ENSP00000354347

UniGene: Hs.580300

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*